Prophylaxis of hepatitis B virus recurrence after liver transplantation

J Gastrointestin Liver Dis. 2009 Jun;18(2):139-41.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Antiviral Agents / economics
  • Cost-Benefit Analysis
  • DNA, Viral / blood
  • Drug Costs
  • Drug Therapy, Combination
  • Female
  • Health Care Costs
  • Hepatitis B / diagnosis
  • Hepatitis B / economics
  • Hepatitis B / immunology
  • Hepatitis B / prevention & control*
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Humans
  • Immunoglobulins, Intravenous / administration & dosage*
  • Immunoglobulins, Intravenous / economics
  • Lamivudine / administration & dosage*
  • Lamivudine / economics
  • Liver Transplantation / adverse effects*
  • Liver Transplantation / economics
  • Male
  • Middle Aged
  • Patient Selection*
  • Secondary Prevention
  • Viral Load

Substances

  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Immunoglobulins, Intravenous
  • Lamivudine